Search for a command to run...
No recent news available for this stock.
Conference call summary is not available for this stock.
In the Pharmaceuticals & Drugs sector, MPS Pharmaa Ltd. shows significant underperformance compared to its peers, characterized by zero growth metrics and negative valuation ratios. However, companies like Sun Pharmaceutical and Cipla stand out with strong profitability and growth, while others like Divi's Laboratories show high valuations despite weak revenue growth. MPS Pharmaa Ltd. is positioned as a value pick due to its low market price but lacks profitability and growth metrics.
Highest revenue growth (YoY: 8.42%) and strong ROE (16.13%) with manageable debt.
Strong profitability (ROE: 16.63%) and good revenue growth (YoY: 13.28%) with low PEG ratio (0.35).